C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
||this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person.
||represents the weighted average sale price. the lowest price at which shares were sold was $34.58 and the highest price at which shares were sold was $35.53. the reporting person undertakes to provide upon request to the staff of the securities and exchange commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this form 4.
||represents the weighted average sale price. the lowest price at which shares were sold was $35.64 and the highest price at which shares were sold was $35.90.
||the option vests as to 1/4 of the total shares on september 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on august 9, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. the option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.